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Altered homeostasis of metal ions is suspected to play a critical role in neurodegeneration. However, the lack of analytical
technique with sufficient spatial resolution prevents the investigation of metals distribution in neurons. An original
experimental setup was developed to perform chemical element imaging with a 90 nm spatial resolution using synchrotron-
based X-ray fluorescence. This unique spatial resolution, combined to a high brightness, enables chemical element imaging in
subcellular compartments. We investigated the distribution of iron in dopamine producing neurons because iron-dopamine
compounds are suspected to be formed but have yet never been observed in cells. The study shows that iron accumulates into
dopamine neurovesicles. In addition, the inhibition of dopamine synthesis results in a decreased vesicular storage of iron.
These results indicate a new physiological role for dopamine in iron buffering within normal dopamine producing cells. This
system could be at fault in Parkinson’s disease which is characterized by an increased level of iron in the substancia nigra pars
compacta and an impaired storage of dopamine due to the disruption of vesicular trafficking. The re-distribution of highly
reactive dopamine-iron complexes outside neurovesicles would result in an enhanced death of dopaminergic neurons.
Citation: Ortega R, Cloetens P, Deve `s G, Carmona A, Bohic S (2007) Iron Storage within Dopamine Neurovesicles Revealed by Chemical Nano-
Imaging. PLoS ONE 2(9): e925. doi:10.1371/journal.pone.0000925
INTRODUCTION
The complete understanding of what is the chemical basis of the
neuron cells is a major challenge that requires the development of
new single-cell analytical methods. For example, very little is
known about the distribution of metal ions such as iron, zinc, or
copper, in neurons at the subcelullar level. However, those
chemical elements have essential regulatory functions and their
disturbed homeostasis is involved in neurodegenerative diseases
[1,2] such as Alzheimer’s disease, Huntington’s disease, or
Parkinson’s disease (PD). Anomalous iron handling has been
proposed to be involved in the selective loss of dopaminergic
neurons from the substancia nigra pars compact (SNpc) in PD
[3,4]. Indeed, iron specific accumulation in the SNpc is associated
with PD [5–7]. This phenomenon is still unexplained. The role of
iron in the etiology of PD is also supported by pharmacological
evidence; a number of iron chelators have been shown to attenuate
PD symptoms in animal models [2,8,9], confirming that iron could
either mediate or accentuate neurotoxicity. Because dopamine can
form stable complexes with iron in vitro [10,11], it has been
suggested that dopamine may exert a protective effect by chelating
iron in dopaminergic neurons and that this system might be at
fault in PD [12]. It is therefore theoretically possible that
dopamine-iron complexes may exist in dopaminergic neurons
but they have not yet been evidenced experimentally. The
question then arises whether the dopamine-iron complex occurs
in vivo and if so, where?
Chemical imaging is the simultaneous measurement of chemical
information and spatial information. Up to now the lack of
analytical techniques with sufficient spatial resolution and de-
tection sensitivity prevented the study of iron distribution in
neurons at the subcelullar level. We developed an original setup
for high spatial resolution chemical imaging at the European
Synchrotron Radiation Facility (Fig. 1A, B) with a 88 nm X-ray
beam of very high flux (up to 10
12 photons/s). This spatial
resolution is ten times better than what was available up to now for
hard X-ray chemical imaging [13]. The characteristics of this
unique nanoprobe fulfill the requirements for mapping biological
trace element distributions at a size compatible with the analysis of
most cellular compartments such as mitochondria, lysosomes, or
neurosecretory vesicles. As exemplified in Figure 1, this newly
developed synchrotron X-ray fluorescence nanoprobe is able to
detect down to 10
218 g of Fe within a cellular structure as small as
100 nm diameter. The aim of this study was to elucidate the role
of dopamine on iron homeostasis in dopaminergic cells by
comparing dopamine and iron distributions in control dopami-
nergic cells and dopaminergic cells exposed to an inhibitor of
dopamine synthesis. Using this chemical nano-imaging system we
investigated the subcellular distribution of iron in dopamine
producing neurons. PC12 rat pheocromocytoma cell line was used
as in vitro model of dopamine producing cells [14,15]. PC12
neuronal cells were differentiated with NGF and exposed in vitro to
sub-cytotoxic concentrations of iron and/or alpha-methyltyrosine
(AMT), an inhibitor of tyrosine hydroxylase (TH), the rate limiting
enzyme in the biosynthesis of dopamine.
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Iron and dopamine distribution in dopamine
producing cells
The iron profile distribution, as retrieved for example from the
region zoomed in figure 1C, shows that iron is localized nearly
exclusively in structures of typically 200 nm in size. Iron rich
structures are not always resolved by the beam and clusters of
larger dimension are also observed. These structures are found in
the cytosol (Fig. 2), neurite outgrowths (Fig. 3), and distal ends
(Fig. 4) of dopamine producing PC12 cells. The combination of
dopamine fluorescence microscopy and synchrotron X-ray
chemical nano-imaging reveals the co-localization of iron and
dopamine in dopamine neurovesicles (Fig. 5C, D). A blue
fluorescence was observed, only for cells exposed to an excess of
iron, which corresponds to the reported fluorescence of oxidized
forms of dopamine [16,17]. When control cells are compared to
cells exposed to an excess of iron, the same subcellular distribution
is found but with a higher number of iron-rich structures in iron-
exposed cells (Fig. 2). The iron content is found particularly high in
neurite outgrowths and distal ends of cells exposed to excess iron
(Fig. 3 and 4). Using the multielemental capabilities of the
synchrotron X-ray fluorescence nanoprobe we were also able to
image the distribution of some other essential chemical elements
such as potassium or zinc (Fig. 2 to 4). Contrary to what is
observed for iron, potassium and zinc are ubiquitous in dopamine
producing cells and not selectively distributed to dopamine
neurovesicles.
Inhibition of dopamine synthesis
To confirm the interaction of dopamine and iron, PC12 cells were
exposed to AMT an inhibitor of TH and consequently of
dopamine synthesis. The inhibition of TH results in a decrease
of the total iron content in PC12 cells (Fig. 6). The decrease of iron
consecutive to AMT treatment was observed both in absence or
presence of excess iron. It is interesting to note that AMT had no
effect on the cellular concentration of zinc (Fig. 6), indicating that
AMT affects selectively the distribution of iron. The decrease of
iron concentration following AMT exposure alone is more
pronounced in neuronal processes, neurite outgrowths and distal
ends, than in cell bodies (Fig. 7). In cells exposed to AMT alone
only a basal level of iron is detected with none or very few iron-
rich structures (Fig. 2 to 4 and 7). Similarly, in cells exposed to iron
and AMT, the number of iron-rich structures is lower than in cells
exposed to iron alone, especially in neurite outgrowths and distal
ends (Fig. 2 to 4 and 7).
DISCUSSION
Dopamine is a neurotransmitter member of the catecholamine
family. It is well established that the biosynthesis of dopamine takes
place in the cytosol from which the neurotransmitter is transported
through a specific transport system into presynaptic vesicles. The
vesicular storage protects dopamine from degradation by the
enzyme monoamine oxidase. In differentiated PC12 cells,
dopamine is known to be stored within large dense core vesicles
of 100–200 nm in the cytosol and neuronal processes (dendrites
Figure 1. Synchrotron X-ray chemical nano-imaging reveals iron sub-cellular distribution. The synchrotron X-ray fluorescence nanoprobe end-
station installed at ESRF was designed to provide a high flux hard X-ray beam of less than 90 nm size (FWHM, full width at half maximum). The
intensity distribution in the focal plane is shown in (A); dopamine producing cells were exposed in vitro to 300 mM FeSO4 during 24 h (B). Chemical
element distributions, here potassium and iron, were recorded on distinct cellular areas such as cell bodies (C), neurite outgrowths, and distal ends
(D). Iron was found in 200 nm structures in the cytosol, neurite outgrowths, and distal ends, but not in the nucleus. Iron rich structures are not always
resolved by the beam and clusters of larger dimension are also observed. Min-max range bar units are arbitrary. Scale bars=1 mm.
doi:10.1371/journal.pone.0000925.g001
Iron in Dopamine Neurovesicles
PLoS ONE | www.plosone.org 2 September 2007 | Issue 9 | e925and axons), with greatest intensity at varicosities, branch points
and distal ends [15,18]. This is exactly what we observed in this
study using epifluorescence microscopy of dopamine distribution
in PC12 cells (Fig. 5). These observations provide the first
experimental evidence that iron and dopamine accumulate into
dopamine vesicles of dopamine producing neurons.
Potassium shows an intracellular distribution proportional to
cell volume (Fig. 2 to 4) as expected from the known ubiquitous
distribution of this element in mammalian cells [19,20]. Similarly,
zinc is ubiquitous within the cell volume, with slightly higher levels
in the nucleus (Fig. 2 to 4). It is also well known that this essential
trace element is involved in numerous protein functions in all
cellular compartments, including zinc-finger transcription factors
in the nucleus [21]. Zinc does not co-localize with iron in
dopamine neurovesicles which suggests a selective interaction
between dopamine and iron.
It is interesting to note that AMT, an inhibitor of dopamine
synthesis, had no effect on the cellular concentration of zinc
(Fig. 6), indicating that AMT affects selectively the distribution of
iron. The decrease of iron concentration following AMT exposure
alone is more pronounced in neuronal processes, neurite out-
growths and distal ends, than in cell bodies (Fig. 7). Therefore, the
inhibition of dopamine synthesis induces a decrease in total iron
Figure 2. Nano-imaging of potassium, iron, and zinc in cell bodies.
Each series of images are representative of the entire cell population for
each condition (control, 1mM AMT and/or 300 mM FeSO4). The scanned
area (left images, red squares) is shown on a bright field microscopy
view of the freeze dried cell. Iron is located within the cytosol in vesicles
of 200 nm size or more (Control). In cells exposed to iron alone Fe, and
to AMT+Fe, a larger number of iron-rich structures are observed in cell
bodies. In cell bodies of cells exposed to AMT alone, only a basal level of
diffused iron is observed and almost no iron-rich structures. Min-max
range bar units are arbitrary for potassium and zinc distributions. For
iron distribution the maximum threshold values in micrograms per
squared centimeter are shown for each color scale. Scale bars=1 mm.
doi:10.1371/journal.pone.0000925.g002
Figure 3. Nano-imaging of potassium, iron, and zinc in neurite
outgrowths. Each series of images are representative of the entire cell
population for each condition (control, 1mM AMT and/or 300 mM
FeSO4). The scanned area (left images, red squares) is shown on a bright
field microscopy view of the freeze dried cell. Iron is located within
dopamine vesicles of 200 nm size or more in control cells with a large
number of Fe-dopamine structures in Fe exposed cells. Iron concen-
tration is close to the limit of detection in neurites of AMT cells. Min-
max range bar units are arbitrary for potassium and zinc distributions.
For iron distribution the maximum threshold values in micrograms per
squared centimeter are shown for each color scale. Scale bars=1 mm.
doi:10.1371/journal.pone.0000925.g003
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confirms the storage of iron in dopamine vesicles and also suggests
a physiological role of dopamine in the control of iron homeostasis
in dopaminergic cells.
The observation of a basal level of iron after inhibition of
dopamine synthesis (Fig. 2 to 4 and 7) indicates that dopamine
vesicles are not the only sites for iron storage. The iron storage
protein ferritin is synthesized by PC12 cells [22,23] and ferritin
molecules are known to be present in axons of neuronal cells [24].
Redox metals such as iron do not appear free in solution to any
extent in healthy living systems because of their highly toxic
reactivity. Both systems, ferritin and dopamine, could contribute
to iron storage in dopaminergic cells. In addition, it can be
speculated that our observation of iron-dopamine structures in
neurite outgrowths could also be related to the axonal transport of
iron from the cytosol to the synapse [25,26].
PD results from a shortage of dopamine in the brain induced by
the selective death of dopamine producing neurons in the SNpc
[27] Dopaminergic neurons die in a slow but progressive manner
leading to a depletion of dopamine in the striatum compromising
the capacity of the brain to orchestrate voluntary movement. The
causes of the selective death of SNpc dopaminergic neurons in PD
are still largely unknown. Increasing evidence suggests that
abnormal iron handling in the brain may be involved in PD
etiology [1–4]. PD is both characterized by iron specific
accumulation in the SNpc [3–7], and by a decrease in TH
protein content and TH mRNA in SNpc dopaminergic neurons
relative to control subjects [28,29]. Our results suggest that the
elevation of iron concentration in the SNpc, and the concomitant
loss of TH hydroxylase activity, may lead to a lack of iron-
dopamine binding capability rendering the dopaminergic neurons
Figure 4. Nano-imaging of potassium, iron, and zinc in distal ends.
Each series of images are representative of the entire cell population for
each condition (control, 1mM AMT and/or 300 mM FeSO4). The scanned
area (left images, red squares) is shown on a bright field microscopy
view of the freeze dried cell. Iron is located within dopamine vesicles of
200 nm size or more (Control, and Fe conditions). Iron concentration is
close to the limit of detection in distal ends of AMT, and AMT+Fe cells;
only a basal level of Fe is observed. Min-max range bar units are
arbitrary for potassium and zinc distributions. For iron distribution the
maximum threshold values in micrograms per squared centimeter are
shown for each color scale. Scale bars=1 mm.
doi:10.1371/journal.pone.0000925.g004
Figure 5. Iron is localized within dopamine neurovesicles. Visible light
microscopy of freeze-dried cells (A), and epifluorescence microscopy of
the same freeze-dried cells (B) enable the identification of dopamine
distribution, while synchrotron X-ray fluorescence nano-imaging reveals
the distribution of iron (C, D). Panels C and D represent comparison of
the same region imaged in a fluorescent mode to visualize dopamine
and with X-ray fluorescence to localize iron. Dopamine and iron are co-
located within 200 nm structures characteristic of dopamine neurove-
sicles as identified by epifluorescence microscopy. A large number of
iron and dopamine neurovesicles are found in neurite outgrowths (C)
and distal ends (D). Min-max range bar units are arbitrary. Scale
bars=1 mm.
doi:10.1371/journal.pone.0000925.g005
Figure 6. Cellular iron and zinc concentrations (mg/g dry mass;
mean6SD; n=6), obtained by PIXE quantitative micro-analysis. The
data are the mean of six independent analyses performed on areas
containing several hundred of cells for each condition of culture. The
inhibition of dopamine synthesis (AMT, and AMT+Fe) results in
a decrease of total iron concentration, while zinc concentration is not
changed, suggesting a specific role of dopamine in iron homeostasis.
doi:10.1371/journal.pone.0000925.g006
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mutations in a-synuclein, a protein mutated in some familial forms
of PD, could result in a reduced number of vesicles being available
for dopamine storage, leading to an accumulation of dopamine in
the cytoplasm and increased levels of oxidative stress [30,31]. In
this context, a mechanism involving iron in PD progression could
result from the decrease of dopamine neurovesicles and the
redistribution of highly oxidant iron-dopamine compounds in
dopaminergic neurons. Using synchrotron X-ray chemical nano-
imaging it will now be possible to study iron distribution in cellular
models of PD dopaminergic neurons, and more generally, to
investigate the subcellular distribution of any metal ion involved
either in neurodegenerative diseases, or in physiological neuronal
functions.
MATERIALS AND METHODS
Synchrotron X-ray fluorescence chemical nano-
imaging.
Synchrotron undulator radiation is focused efficiently using
dynamically bent graded multilayers set in the Kirkpatrick-Baez
geometry [32]. While this geometry is classical in X-ray optics
[33], it is here extended, in combination with one of the world
most brilliant X-ray sources, to an unprecedented spatial
resolution and photon density. Both properties are however
required for quantitative mapping of trace elements at the sub-
cellular level. The spatial extent of the nanoprobe is below 90 nm
in both directions. The experiments were conducted on a long,
coherent beamline (ID19) and on a shorter beamline using the
concept of a secondary source (the nano-imaging facility ID22NI).
The first mirror of the X-ray optical device, coated with a graded
multilayer, plays both the role of vertical focusing device and
monochromator, resulting in a very high and unique X-ray flux (a
few 10
12 photons/s) at energies between 15 and 17 keV. The
sample, mounted in air on a piezo nano-positioner stage, is scanned
through the focal plane while the spectrum of the emitted
fluorescence is recorded with an energy dispersive Si(Li) detector.
The integration time per scan point was varied inthe range 300 ms–
1 s and kept below the onset of structural radiation damage as
verified by repetitive sampling of the same specimen region.
Quantitative mapping of iron distribution
The X-ray fluorescence recorded spectra are fitted to obtain
quantitative maps of the elements expressed in nanograms per
square centimeters [34]. The analysis of a certified reference
material (Micromatter 4016), consisting in a Zn thin film deposit of
63.3 mg/cm
265%, enabled to calibrate the element concentra-
tions. Iron concentrations in subcellular compartments (cell body,
neurite outgrowths, and distal ends) were determined using
PyMCA software [35] which enables to extract data from selected
zones of the scanned area, and to fit corresponding X-ray
fluorescence spectra. Mean iron quantitative distributions and
standard deviation of the mean in subcellular compartments were
calculated for each culture condition.
Cell cultures and sample preparation
Rat pheochromocytoma PC12 cells were used as in vitro model of
dopamine producing cells [14,15]. PC12 cells were routinely
maintained in RPMI 1640 medium, 4.5 g/L glucose, 10% equine
serum, 5% fetal bovine serum, 2 mM glutamine and 100 U/mL
penicillin-streptomycin, at 37uC in a water-saturated atmosphere
containing 5% CO2. All chemical and biochemical compounds
were from Sigma. About 2.10
4 PC12 cells were split directly onto
2 cm diameter sample holders consisting in a 2 mm thin
polycarbonate foils for synchrotron X-ray fluorescence nano-
imaging, or micro-PIXE (particle induced X-ray emission)
analysis. Cells were allowed to differentiate with 100 ng/mL
nerve growth factor and exposed to 300 mM FeSO4 during 24 h,
to 1 mM AMT during 96 h, or to both compounds. These AMT
and iron concentrations were found sub-cytotoxic as verified on
separate experiments by cell counting assays. After appropriate
exposure times, PC12 cells were rinsed with phosphate buffer
solution, cryofixed at 2160uC by plunge freezing into isopentane
chilled with liquid nitrogen, and freeze dried at 235uC. This
protocol was applied to maintain cellular morphology and
chemical element distribution integrity [20].
Particle induced X-ray emission (PIXE)
Micro-PIXE analysis was performed to obtain quantitative
element concentrations on groups of several hundred cells on
the same samples to complete synchrotron X-ray fluorescence
nano-imaging of single cells. PIXE and Rutherford Backscattering
Spectrometry (RBS) were performed simultaneously using the
nuclear microprobe beamline at the Centre d’Etudes Nucle ´aires
de Bordeaux Gradignan (CENBG), France. The nuclear micro-
probe enables quantitative chemical analysis of trace elements in
cells [13]. In brief, the energy of the incident proton beam
produced by the Van de Graaff accelerator was 2.5 MeV. The
beam was focused onto the sample surface to a spot of 5 mmi n
diameter, resulting in a proton beam current of 250 pA as measured
with a Faraday cup below the sample. X-ray fluorescence
measurements were made with a Si(Li) energy dispersive detector
placed at 45u from the incident beam direction. The RBS
measurements were performed using a PIPS detector (passivated
implanted planar silicon) placed at 135u. X-ray fluorescence data
were analyzed with the Gupix software, used to compute X-ray
attenuation within sample and variation in ionization and emission
cross sections during slowing down of incoming particles. RBS data
were analyzed with SIMNRA code and were used for mass
normalization of X-ray emission leading to quantitative results
expressed in terms of mg of element per g of sample.
Figure 7. Sub-cellular iron quantitative distribution in cell bodies,
neurite outgrowths, and distal ends (ng/cm
2 ; mean6SD; n=4 to 6),
obtained through synchrotron X-ray fluorescence nanoprobe analysis
shows that iron content is decreased particularly in neurite outgrowths
and distal ends after AMT exposure (AMT and AMT+Fe), indicating that
the decrease of total iron concentration is related to the reduction of
the number of iron-dopamine neurovesicles.
doi:10.1371/journal.pone.0000925.g007
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Dopamine fluorescence was observed immediately after freeze
drying using an epifluorescence microscope (Olympus) with
a combination of filters (U-MWU2) that coordinates excitation
at 320–370 nm and allows observation of emission in the 420–
600 nm range. Dopamine fluorescence was observed only in the
case of cells exposed to an excess of iron. The observed
fluorescence of dopamine is due to the formation of a fluorochrome
compound after ring closure of dopamine. Oxidized catechola-
mines are fluorochromes with reported peak absorption and
emission wavelengths respectively at 340–360 nm and 410–
440 nm [16]. In the case of dopamine, oxidized dopamine
absorbs at 335 nm and emits fluorescence with a maximum at
470 nm [17] which corresponds to the blue fluorescence observed
in this study.
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